Follow the company. Check the evidence.
Public records connected to stocks traded by Congress. See what changed, when it became public, and the original source.
ABT: third_quarter 2026 lobbying report
Lobbying issues related to veterans healthcare.
Public: Oct 14, 2026, 5:43 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
ABT: third_quarter 2026 lobbying report
Issues related to federal tax policy. Issues related to medical device reimbursement, cybersecurity, and supply chains. Issues related to diagnostic testing. Issues related to the supply of infant formula and nutrition.
Public: Oct 6, 2026, 1:08 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
ABT: Company disclosure · Other company developments
Filed 8-K for an event or period dated 2026-08-20. Company disclosure; Other company developments.
2 congressional households disclosed purchases in the past 90 days. See the trades
Foreign-Trade Zone (FTZ) 39, Notification of Proposed Production Activity; Abbott Laboratories; (Diagnostic Medical Devices); Irving, Texas
A Notice notice explicitly mentions the company. Read the cited text for its role.
Public: Aug 6, 2026Original source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
ABT: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-06-30. Read the company report for its disclosures.
2 congressional households disclosed purchases in the past 90 days. See the trades
ABT: second_quarter 2026 lobbying report
S.2003 The Strengthening Benefit Plans Act of 2025. Proposals related to The United States-Mexico-Canada Agreement (USMCA). Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations. Proposals related to data privacy/data collection, usage and retention. S.2426/H.R.3164 Equitable Community Access to Pharmacist Services Act. S.4118/H.R.7966 The Hospice Care Accountability, Reform and Enforcement Act of 2026. Proposals related to the advancement, testing and detection of Traumatic Brain Injury (TBI). Proposals related to Department
Public: Jul 20, 2026, 4:41 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
ABT: second_quarter 2026 lobbying report
Issues related to OECD tax negotiations.
Public: Jul 20, 2026, 2:56 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
ABT: second_quarter 2026 lobbying report
Issues related to infant formula access. Issues related to DMEPOS reimbursement by CMS. H.R.2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes.
Public: Jul 20, 2026, 2:33 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
ABT: second_quarter 2026 lobbying report
Issues related to trade and supply chains.
Public: Jul 20, 2026, 1:17 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
ABT: second_quarter 2026 lobbying report
Issues related to S. 1821 - Tackling Predatory Litigation Funding Act; Issues related to S. 2003 - Strengthening Benefits Plan Act. Issues related to S. 2003 - Strengthening Benefits Plan Act.
Public: Jul 20, 2026, 12:45 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
ABT: second_quarter 2026 lobbying report
A lobbying activity report was filed. Income and expenses are separate reporting measures and must not be added together.
Public: Jul 20, 2026, 12:22 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
ABT: second_quarter 2026 lobbying report
Issues related to global health policy and funding; Issues related to H.R. 8595 - National Security, Department of State, and Related Programs Appropriations Act, 2027. Issues related to global health policy and funding.
Public: Jul 19, 2026, 3:27 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
ABT: second_quarter 2026 lobbying report
Issues related to infant formula Equitable Access to Community Pharmacist Services Act Equitable Access to Community Pharmacist Services Act Proposals to reform domestic and international tax structures
Public: Jul 17, 2026, 12:34 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
ABT: Financial results
Filed 8-K for an event or period dated 2026-07-16. Financial results.
2 congressional households disclosed purchases in the past 90 days. See the trades
ABT: second_quarter 2026 lobbying report
Issues related to infant formula, including H.R. 2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula. Proposals related to Medicare coverage of continuous glucose monitors. Issues related to cancer diagnostics national coverage determination. H.R.3512 - Tackling Predatory Litigation Funding Act. Issues related to TRICARE coverage of diabetes management devices.
Public: Jul 9, 2026, 6:18 AM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
ABT: second_quarter 2026 lobbying report
Issues related to the supply of infant formula and nutrition. Issues related to federal tax policy. Issues related to medical device reimbursement. Issues related to diagnostic testing.
Public: Jul 8, 2026, 1:44 PM EDTOriginal source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; Including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots
This proposed rule would revise the Medicare Hospital Outpatient Prospective Payment System (OPPS) and the Medicare Ambulatory Surgical Center (ASC) payment system for calendar year 2027 based on our continuing experience with these systems. We also describe the changes to the amounts and factors used to determine the payment rates for Medicare services paid under the OPPS and those paid under the ASC payment systems. In addition, this proposed rule would update and refine the requirements for the Hospital Outpatient Quality Reporting Program and the Ambulatory Surgical Center Quality Reporting Program. There are no changes to the Rural Emergency Hospital Quality Reporting Program. We propose to expand the prior authorization requirement to include additional Botulinum Toxin Injection services. We also propose to implement certain provisions of the Consolidated Appropriations Act, 2026, for off-campus outpatient departments of a provider. In addition, this proposed rule announces notices of closure of teaching hospitals and opportunities to apply for available slots. This rule also requests information regarding potential approaches to improve comparability and standardization, particularly for complex contracting methodologies, of the HPT information reported in machine- readable files and consumer-friendly displays. We propose hospital AOs with deeming authority to assess compliance with certain Emergency Medical Treatment and Labor Act (EMTALA) administrative requirements during accreditation and reaccreditation surveys. Finally, we are soliciting comments on a potential separate payment under the Inpatient Prospective Payment System (IPPS) for domestic procurement of personal protective equipment and essential medicines.
Public: Jul 7, 2026Original source ↗2 congressional households disclosed purchases in the past 90 days. See the trades
ABT: Stratton John G reported buying shares
1 reported purchase of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.
2 congressional households disclosed purchases in the past 90 days. See the trades
Drugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Syntest D.S. and Syntest H.S. Tablets; Withdrawal of Hearing Requests; Final Resolution of Drug Efficacy Study Implementation 7661
The Food and Drug Administration (FDA or Agency) is announcing that all outstanding hearing requests for estrogen-androgen fixed- combination drug products under Docket FDA-1998-P-0083 (formerly 76N- 0377) (DESI 7661) have been withdrawn. Therefore, as proposed in the April 14, 2003, notice of opportunity for hearing (NOOH), FDA finds that the products subject to this proceeding have not been shown to be effective for use under the conditions of use prescribed, recommended, or suggested in the labeling. Shipment in interstate commerce of any product identified in this docket (DESI 7661), or any identical, related, or similar (IRS) product, that is not the subject of an approved new drug application (NDA) or abbreviated new drug application (ANDA) is unlawful as of the date of this notice.
2 congressional households disclosed purchases in the past 90 days. See the trades
Connections describe public records, not evidence of wrongdoing or a prediction of returns. Event dates can precede publication by days or months. When a source has no public-release timestamp, we show when we first observed it.
Source coverage
Coverage is growing across companies already tracked here. A scan can return no matching records. This feed is not a complete record of every filing or agency action.
- SEC EDGAR
- Current across tracked companies505 of 505 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:26 PM EST
- USAspending
- Collection in progress72 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:27 PM EST
- SAM.gov
- Awaiting company connections
- Lobbying disclosures
- Not yet scanned0 of 548 companies scanned in the past 12 hours
- Congress.gov
- Current across tracked companies5 of 5 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:19 PM EST
- Federal Register
- Collection in progress296 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:27 PM EST
- Regulations.gov
- Partial coverage — some requests unavailable32 of 53 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:19 PM EST
- FEC campaign finance
- Stale — refresh overdue0 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 11, 2026, 1:28 PM EST